Ashwagandha

Ashwagandha leaf powder

Products
2
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 2 labeled products
Min
20 mg
Typical
1.01 g
Max
2 g
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Top brands carrying Ashwagandha leaf powder

15 brands rolled up

Products containing Ashwagandha leaf powder

2 in catalog